160 related articles for article (PubMed ID: 37487828)
1. A meta-analysis of prognostic factors for early recurrence in perihilar cholangiocarcinoma after curative-intent resection.
Tian Y; Wen N; Li B; Lu J; Wang Y; Wang S; Cheng N
Eur J Surg Oncol; 2023 Nov; 49(11):106982. PubMed ID: 37487828
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
[TBL] [Abstract][Full Text] [Related]
4. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
5. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review and Meta-Analysis of Prognostic Factors for Early Recurrence in Intrahepatic Cholangiocarcinoma After Curative-Intent Resection.
Choi WJ; Williams PJ; Claasen MPAW; Ivanics T; Englesakis M; Gallinger S; Hansen B; Sapisochin G
Ann Surg Oncol; 2022 Feb; ():. PubMed ID: 35181812
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
8. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
10. Redefining resection margins and dissection planes in perihilar cholangiocarcinoma-radical resection is a rare event.
D'Souza MA; Al-Saffar HA; Fernández Moro C; Shtembari S; Danielsson O; Sparrelid E; Sturesson C
Virchows Arch; 2022 Mar; 480(3):557-564. PubMed ID: 34783866
[TBL] [Abstract][Full Text] [Related]
11. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
[TBL] [Abstract][Full Text] [Related]
12. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group.
Ruzzenente A; Bagante F; Olthof PB; Aldrighetti L; Alikhanov R; Cescon M; Koerkamp BG; Jarnagin WR; Nadalin S; Pratschke J; Schmelzle M; Sparrelid E; Lang H; Iacono C; van Gulik TM; Guglielmi A;
Ann Surg Oncol; 2021 Nov; 28(12):7719-7729. PubMed ID: 33956275
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
14. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.
Kuriyama N; Usui M; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kishiwada M; Sakurai H; Mizuno S; Isaji S
BMC Cancer; 2020 May; 20(1):405. PubMed ID: 32393197
[TBL] [Abstract][Full Text] [Related]
18. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
[TBL] [Abstract][Full Text] [Related]
19. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review.
Kambakamba P; Linecker M; Slankamenac K; DeOliveira ML
Am J Surg; 2015 Oct; 210(4):694-701. PubMed ID: 26212390
[TBL] [Abstract][Full Text] [Related]
20. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.
Zhang Y; Wu Z; Wang X; Li C; Chang J; Jiang W; Wang H; Wang Y; Li X
BMC Cancer; 2020 Oct; 20(1):1044. PubMed ID: 33126868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
